CO2022013833A2 - Composiciones de virus adenoasociados para la transferencia del gen ids y sus métodos de uso - Google Patents

Composiciones de virus adenoasociados para la transferencia del gen ids y sus métodos de uso

Info

Publication number
CO2022013833A2
CO2022013833A2 CONC2022/0013833A CO2022013833A CO2022013833A2 CO 2022013833 A2 CO2022013833 A2 CO 2022013833A2 CO 2022013833 A CO2022013833 A CO 2022013833A CO 2022013833 A2 CO2022013833 A2 CO 2022013833A2
Authority
CO
Colombia
Prior art keywords
methods
adeno
associated virus
compositions
gene transfer
Prior art date
Application number
CONC2022/0013833A
Other languages
English (en)
Inventor
Jacinthe Gingras
Kruti Patel
Laura Jane Smith
Yvonne White
Serena Nicole Dollive
Lieshout Laura Van
Brenda Burnham
Original Assignee
Homology Medicines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Homology Medicines Inc filed Critical Homology Medicines Inc
Publication of CO2022013833A2 publication Critical patent/CO2022013833A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/06—Sulfuric ester hydrolases (3.1.6)
    • C12Y301/06013—Iduronate-2-sulfatase (3.1.6.13)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A01K2217/077—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se proporcionan composiciones de virus adenoasociados (AAV) que pueden restaurar la función del gen IDS en las células, y métodos para usar estas composiciones de AAV para tratar trastornos asociados con la reducción de la función del gen IDS (por ejemplo, síndrome de Hunter). También se proporcionan composiciones, sistemas y métodos para preparar las composiciones de AAV.
CONC2022/0013833A 2020-04-06 2022-09-27 Composiciones de virus adenoasociados para la transferencia del gen ids y sus métodos de uso CO2022013833A2 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063005833P 2020-04-06 2020-04-06
US202063094800P 2020-10-21 2020-10-21
US202163145258P 2021-02-03 2021-02-03
PCT/US2021/025785 WO2021207077A1 (en) 2020-04-06 2021-04-05 Adeno-associated virus compositions for ids gene transfer and methods of use thereof

Publications (1)

Publication Number Publication Date
CO2022013833A2 true CO2022013833A2 (es) 2022-10-31

Family

ID=78022877

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0013833A CO2022013833A2 (es) 2020-04-06 2022-09-27 Composiciones de virus adenoasociados para la transferencia del gen ids y sus métodos de uso

Country Status (13)

Country Link
US (1) US20210361778A1 (es)
EP (1) EP4132562A4 (es)
JP (1) JP2023522852A (es)
KR (1) KR20220164743A (es)
CN (1) CN115484975A (es)
AU (1) AU2021252515A1 (es)
BR (1) BR112022019182A2 (es)
CA (1) CA3173207A1 (es)
CO (1) CO2022013833A2 (es)
IL (1) IL296986A (es)
MX (1) MX2022012407A (es)
TW (1) TW202204629A (es)
WO (1) WO2021207077A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023060264A1 (en) 2021-10-08 2023-04-13 Dyno Therapeutics, Inc. Capsid variants and methods of using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461606B1 (en) * 1998-04-24 2002-10-08 University Of Florida Research Foundation Materials and methods for gene therapy
US7985553B2 (en) * 2001-10-29 2011-07-26 Nathaniel Heintz Method for isolating cell type-specific mRNAs
US8227212B2 (en) * 2003-02-11 2012-07-24 Shire Human Genetic Therapies, Inc. Cell that expresses a sulfatase and a formylglycine generating enzyme
US8628966B2 (en) * 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US20180127733A9 (en) * 2010-11-12 2018-05-10 Green Cross Corporation Iduronate-2-sulfatase and use thereof
WO2013151664A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
SG11201605906UA (en) * 2014-01-21 2016-08-30 Univ Bruxelles Muscle-specific nucleic acid regulatory elements and methods and use thereof
EP3116533B1 (en) * 2014-03-12 2020-08-12 Precision Biosciences, Inc. Dystrophin gene exon deletion using engineered nucleases
EP3101125A1 (en) * 2015-06-05 2016-12-07 Laboratorios Del Dr. Esteve, S.A. Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
IL262211B2 (en) * 2016-04-15 2024-01-01 Univ Pennsylvania Gene therapy for the treatment of type II mucositis
JP7119009B2 (ja) * 2017-05-31 2022-08-16 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 最適化されたヒト凝固第ｉｘ因子遺伝子発現カセットおよびそれらの使用
JP2021500070A (ja) * 2017-10-18 2021-01-07 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ Ｈｂｂ遺伝子機能を回復させるためのアデノ随伴ウイルス組成物およびその使用方法
US20190256867A1 (en) * 2018-02-01 2019-08-22 Homology Medicines, Inc. Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
JP2023505851A (ja) * 2019-12-10 2023-02-13 武田薬品工業株式会社 ハンター病治療用のアデノ随伴ウイルスベクター

Also Published As

Publication number Publication date
WO2021207077A1 (en) 2021-10-14
US20210361778A1 (en) 2021-11-25
CN115484975A (zh) 2022-12-16
JP2023522852A (ja) 2023-06-01
TW202204629A (zh) 2022-02-01
MX2022012407A (es) 2022-10-28
BR112022019182A2 (pt) 2022-11-29
IL296986A (en) 2022-12-01
EP4132562A4 (en) 2024-04-17
CA3173207A1 (en) 2021-10-14
EP4132562A1 (en) 2023-02-15
AU2021252515A1 (en) 2022-10-27
KR20220164743A (ko) 2022-12-13

Similar Documents

Publication Publication Date Title
CL2017002731A1 (es) Adenovirus oncolítico que codifica una proteína b7
BR112018011711A2 (pt) peptídeos de direcionamento para direcionar virus adeno-associados (aav)
EA202091615A1 (ru) Интраназальные составы на основе эпинефрина и способы лечения заболевания
BR112019001887A2 (pt) composições e métodos para o tratamento de doença associada a cep290
CO2020010783A2 (es) Composiciones de virus adeno-asociadas para la transferencia de genes pah y métodos de uso de los mismos
BR112021022666A2 (pt) Frações de separação e seus métodos e uso
AR118734A1 (es) Formulaciones y métodos de vectores de virus adenoasociados
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
MX2020004092A (es) Composiciones de virus adenoasociados para restaurar la funcion del gen hbb y metodos de uso de estas.
AR113134A1 (es) Arni variante
BRPI0618486A2 (pt) uso de células progenitoras multipotentes em adultos
CO2022013833A2 (es) Composiciones de virus adenoasociados para la transferencia del gen ids y sus métodos de uso
CO2021016797A2 (es) Composiciones de virus adenoasociadas para la transferencia del gen arsa y métodos de uso de las mismas
AR116569A1 (es) Terapia génica para tratar la acidemia propiónica
CO2022018370A2 (es) Composiciones de virus adenoasociados para restaurar la función del gen pah y los métodos de uso de estas
CO2020010793A2 (es) Composiciones de virus adeno-asociado para restaurar la función del gen pah y métodos de uso de las mismas
AR122013A1 (es) Composiciones de virus adenoasociados compatibles entre especies y métodos para su uso
CO2021013970A2 (es) Células t específicas del antígeno del virus multi-respiratorio y métodos para fabricar y usar el mismo terapéuticamente
BR112018072701A2 (pt) métodos de tratamento de leucemia mieloide aguda e mieloma múltiplo usando células exterminadoras naturais
CL2021002807A1 (es) Anticuerpos y métodos para el tratamiento de la infección por influenza a
CL2020002650A1 (es) Enzimas quinureninasa humanas y sus usos
CL2020002566A1 (es) Composiciones aav, métodos de fabricación y métodos de uso
BR112022006476A2 (pt) Oligonucleotídeos com análogos de nucleosídeos
AR120048A1 (es) Uso de virus oncolíticos para el tratamiento del cáncer
AR121770A1 (es) Composiciones de virus adenoasociados para la trasferencia del gen ids y sus métodos de uso